Patents by Inventor Nikolay Khanzhin

Nikolay Khanzhin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted morpholine and thiomorpholine derivatives
    Patent number: 7501414
    Abstract: The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: March 10, 2009
    Assignee: H. Lundbeck A/S
    Inventors: Christian Wenzel Tornøe, Mario Rottländer, Nikolay Khanzhin, Andreas Ritzèn, William Patrick Watson
  • Substituted Pyridine Derivatives
    Publication number: 20080318953
    Abstract: The present invention relates to pyridine derivatives of the general formula (I) and their use as openers of the KCNQ family potassium ion channels for the treatment of CNS disorders.
    Type: Application
    Filed: March 2, 2006
    Publication date: December 25, 2008
    Applicant: H. LUNDBECK A/S
    Inventors: Christian Wenzel Tornoe, Nikolay Khanzhin, Mario Rottlander, William Patrick Watson, Daniel Rodriguez Greve
  • 1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system
    Patent number: 7368472
    Abstract: The present invention concerns 1,2,4-triaminobenzene derivatives of the general formula I or pharmaceutically acceptable salts thereof and the use thereof.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: May 6, 2008
    Assignee: H. Lundbeck A/S
    Inventors: Mario Rottlander, Andreas Ritzen, Morten Bang Norgaard, Nikolay Khanzhin, Christian Wenzel Tornoe
  • Substituted pyrimidine derivatives
    Publication number: 20070066612
    Abstract: The present invention relates to pyrimidine derivatives of the general formula I or salts thereof and their use.
    Type: Application
    Filed: September 6, 2006
    Publication date: March 22, 2007
    Inventors: Nikolay Khanzhin, Daniel Greve, Mario Rottlander
  • Substituted indoline and indole derivatives
    Publication number: 20060264496
    Abstract: The present invention relates to aniline derivatives of the general formula I or pharmaceutically acceptable salts thereof, [Formula (I)], and their use.
    Type: Application
    Filed: April 23, 2004
    Publication date: November 23, 2006
    Applicant: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Mario Rottlander, William Watson
  • Substituted p-diaminobenzene derivatives
    Publication number: 20060183791
    Abstract: The present invention relates to aniline derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.
    Type: Application
    Filed: March 18, 2004
    Publication date: August 17, 2006
    Applicant: H. LUNDBECK A/S
    Inventors: Nikolay Khanzhin, Mario Rottlander, Andreas Ritzen, William Watson
  • Substituted morpholine and thiomorpholine derivatives
    Publication number: 20060167248
    Abstract: The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.
    Type: Application
    Filed: December 21, 2005
    Publication date: July 27, 2006
    Inventors: Christian Tornoe, Mario Rottlander, Nikolay Khanzhin, Andreas Ritzen, William Watson
  • Substituted aniline derivatives
    Publication number: 20060155121
    Abstract: The present invention relates to aniline derivatives of the general formula I or salts thereof and their use.
    Type: Application
    Filed: December 20, 2005
    Publication date: July 13, 2006
    Inventors: Christian Tornoe, Mario Rottlander, Daniel Greve, Nikolay Khanzhin, Andreas Ritzen, William Watson
  • 1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system
    Publication number: 20060014822
    Abstract: The present invention concerns 1,2,4-triaminobenzene derivatives of the general formula I or pharmaceutically acceptable salts thereof and the use thereof.
    Type: Application
    Filed: December 18, 2003
    Publication date: January 19, 2006
    Inventors: Mario Rottlander, Andreas Ritzen, Morten Norgaard, Nikolay Khanzhin, Christian Tornoe